FDA
label_change
· 2016-12-19
FDA Approved: CYTOTEC — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
Summary
FDA approved a supplemental application for Cytotec (misoprostol) from Pfizer Laboratories Div Pfizer Inc, resulting in a labeling update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CYTOTEC (MISOPROSTOL)